Boucher C - Search Results

1

Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age.

Cohen Stuart J, Hamann D, Borleffs J, Roos M, Miedema F, Boucher C, de Boer R. Cohen Stuart J, et al. Among authors: boucher c. AIDS. 2002 Nov 22;16(17):2263-6. doi: 10.1097/00002030-200211220-00005. AIDS. 2002. PMID: 12441797

2

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

Tural C, Ruiz L, Holtzer C, Schapiro J, Viciana P, González J, Domingo P, Boucher C, Rey-Joly C, Clotet B; Havana Study Group. Tural C, et al. Among authors: boucher c. AIDS. 2002 Jan 25;16(2):209-18. doi: 10.1097/00002030-200201250-00010. AIDS. 2002. PMID: 11807305 Clinical Trial.

3

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.

Schuurman R, Brambilla D, de Groot T, Huang D, Land S, Bremer J, Benders I, Boucher CA; ENVA Working Group. Schuurman R, et al. AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):243-8. doi: 10.1089/088922202753472801. AIDS Res Hum Retroviruses. 2002. PMID: 11860670

4

The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).

Haverkamp M, Smit M, Weersink A, Boucher CA, Hoepelman AI. Haverkamp M, et al. AIDS. 2003 Jul 4;17(10):1572-4. doi: 10.1097/00002030-200307040-00023. AIDS. 2003. PMID: 12824802

5

Worldwide transmission of drug-resistant HIV.

Wensing AM, Boucher CA. Wensing AM, et al. AIDS Rev. 2003 Jul-Sep;5(3):140-55. AIDS Rev. 2003. PMID: 14598563 Review.

6

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI. Cohen Stuart JW, et al. J Med Virol. 2009 Mar;81(3):441-5. doi: 10.1002/jmv.21422. J Med Virol. 2009. PMID: 19152397

7

HIV-1 can persist in aged memory CD4+ T lymphocytes with minimal signs of evolution after 8.3 years of effective highly active antiretroviral therapy.

Nottet HS, van Dijk SJ, Fanoy EB, Goedegebuure IW, de Jong D, Vrisekoop N, van Baarle D, Boltz V, Palmer S, Borleffs JC, Boucher CA. Nottet HS, et al. Among authors: boucher ca. J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):345-53. doi: 10.1097/QAI.0b013e318197eb04. J Acquir Immune Defic Syndr. 2009. PMID: 19214126

8

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

Frentz D, Boucher CA, van de Vijver DA. Frentz D, et al. Among authors: boucher ca. AIDS Rev. 2012 Jan-Mar;14(1):17-27. AIDS Rev. 2012. PMID: 22297501 Review.

9

Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study.

Nichols BE, Sigaloff KC, Kityo C, Mandaliya K, Hamers RL, Bertagnolio S, Jordan MR, Boucher CA, Rinke de Wit TF, van de Vijver DA. Nichols BE, et al. Among authors: boucher ca. AIDS. 2014 Jan 2;28(1):73-83. doi: 10.1097/01.aids.0000433239.01611.52. AIDS. 2014. PMID: 23921620

10

Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models.

van de Vijver DA, Nichols BE, Abbas UL, Boucher CA, Cambiano V, Eaton JW, Glaubius R, Lythgoe K, Mellors J, Phillips A, Sigaloff KC, Hallett TB. van de Vijver DA, et al. Among authors: boucher ca. AIDS. 2013 Nov 28;27(18):2943-51. doi: 10.1097/01.aids.0000433237.63560.20. AIDS. 2013. PMID: 23939237

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

842 results

Search Page